Dr. Udit Batra earned a Ph.D. in Chemical and Biological Engineering from Princeton, and is currently the Chief Executive Officer of MilliporeSigma, a $7.6 billion Life Science business of Merck KGaA, Darmstadt, Germany, and a member of the Executive Board of Merck KGaA, Darmstadt, Germany. The Life Science business of Merck KGaA, Darmstadt, Germany operates as MilliporeSigma in the U.S. and Canada. Batra oversees the company's Bioethics Advisory Panel and has Board responsibility for the global Information Technology function.
Born in New Delhi, India, Batra is an accomplished executive who has dedicated his career to improving health for people globally, bringing more than 20 years’ experience in healthcare and the life sciences. After Batra became CEO of what was EMD Millipore in 2014, he and his team developed and executed a growth strategy that included the 2015 acquisition of chemicals and technology giant Sigma-Aldrich. He and his team architected and led this merger to create MilliporeSigma — the largest acquisition in the history of Merck KGaA, Darmstadt, Germany and one of the largest ever in the life science industry.
Today, Batra continues to lead the business through a strategic transformation that has made MilliporeSigma a top-three player in the industry with organic sales growth consistently exceeding the market and remaining the highest among integrated peers, not to mention an employer of choice in many regions where it operates around the world.